These biotech stocks are getting hammered by shocking brittlebone treatment study results
Dec 29, 2025
Shares of both Ultragenyx and Mereo BioPharma were seeing record selloffs after disappointing trial results for setrusumab.
https://www.marketwatch.com/story/these-biotech-stocks-are-getting-hammered-by-shocking-brittle-bone-treatment-study-results-5bd80501?mod=mw_rss_topstories
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service